Investment
Features
FeesSafety
Academy
More
Pluang+

Warner Bros. Discovery Q2 EPS beats estimates despite revenue miss; streaming revenue hits record $3B.

Company Fundamentals
06 Aug 2026
Stuart Mooney
View Source
Bullish
pluang ai news

Warner Bros. Discovery reported Q2 earnings with an EPS of $0.06, beating the expected loss of -$0.14, showing better profitability despite a drop from last year's $0.63. However, revenue missed estimates at $8.72 billion versus $9.25 billion forecast, impacted by losing the NBA broadcast deal and weaker summer movie performance. The company's streaming segment excelled, generating over $3 billion in revenue and a 60% rise in adjusted EBITDA to $512 million, highlighting strong growth and improved margins. Looking ahead, Warner Bros. Discovery plans to boost film production from 14 to 19 movies in 2027, aiming to leverage popular content to grow its streaming subscriber base.

More News

Arhaus stock jumps 24% on strong Q2 earnings and analyst upgrade to Buy.

Arhaus stock jumps 24% on strong Q2 earnings and analyst upgrade to Buy.

Arhaus reported record Q2 net revenue of $385 million, a 7.4% increase year-over-year, driven by strong customer demand and a 12.5% rise in comparable sales. Earnings per share of $0.28 beat estimates by 75%, supported by a 16.1% increase in gross ma...

Company Fundamentals
Bullish
24 minutes ago
Flutter Entertainment stock falls 13% after earnings miss and CEO departure, Citigroup downgrades to Neutral.

Flutter Entertainment stock falls 13% after earnings miss and CEO departure, Citigroup downgrades to Neutral.

Flutter Entertainment's stock dropped 13% following a significant earnings miss and the announcement of CEO Peter Jackson's departure. The company reported Q2 earnings of $0.49 per share, well below the expected $0.60, and cut its full-year U.S. prof...

Market News
Bearish
27 minutes ago
Attovia Therapeutics raises $332M in upsized IPO, shares debut strong on Nasdaq.

Attovia Therapeutics raises $332M in upsized IPO, shares debut strong on Nasdaq.

Attovia Therapeutics, a clinical-stage biopharmaceutical company, completed an upsized IPO by selling 19.55 million shares, including an underwriter option, raising approximately $332.40 million. The stock opened at $21.00 per share on Nasdaq and rea...

Others
Bullish
39 minutes ago
Aflac posts solid Q2 2026 earnings with $1.75 EPS and strong Japan profitability.

Aflac posts solid Q2 2026 earnings with $1.75 EPS and strong Japan profitability.

Aflac reported Q2 2026 earnings per share of $1.75, slightly below analyst estimates, while revenue of $4.12 billion narrowly exceeded projections. The company's improved profitability in Japan, highlighted by a better benefit-to-premium ratio of 61....

Company Fundamentals
Bullish
42 minutes ago
Stocks plunge as YXT drops 66% after share offering; leveraged ETF APPX falls 39%.

Stocks plunge as YXT drops 66% after share offering; leveraged ETF APPX falls 39%.

YXT.COM Group Holding Limited's stock plunged 66.07% following a registered direct offering that raised concerns about share dilution. The leveraged ETF Tradr 2X Long APP Daily ETF (APPX) fell 39.22%, highlighting the risks of leveraged products. Des...

Market News
Bearish
43 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App